Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00051779
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
2003-01-16
Brief Title:
An Investigational Drug CAL Versus Zoledronic Acid Zometa in Patients With Breast Cancer
Sponsor:
Chugai Pharma USA
Organization:
Chugai Pharma USA
Organization Data
Organization:
Chugai Pharma USA
Class:
INDUSTRY
Study ID:
CAL-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chugai Pharma USA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None